Povidone (PVP): The excipient that quietly decides whether your formulation works
Release Time:
Aug 28,2026
Let's be honest about formulation risk: the API gets all the attention, but the binder is what keeps your tablet together on a high-speed rotary press running at 400,000 tablets per hour. Get the binder wrong and you inherit capping, lamination, weight variation, and a stability profile that drifts batch to batch. Get it right, and the rest of the formula falls into place.
That's why Povidone (PVP) — particularly Povidone K30 and K90 — remains one of the most quietly indispensable excipients in solid oral dosage. Its dual role as a water-soluble binder and granulation aid gives formulators a flexible tool across wet granulation, dry blending, and even hot-melt extrusion for amorphous solid dispersions.
Why formulators keep coming back to PVP
- Binder strength at low use levels — typically 2–5%, reducing total tablet weight.
- Outstanding solubility in water and many organic solvents, making it ideal for both aqueous and solvent-based processes.
- Compatibility with practically every common API class, including poorly soluble BCS Class II and IV compounds.
- Proven regulatory acceptance across USP, Ph.Eur., JP, and IPCC monographs.
As a specialized exporter of pharmaceutical excipients, we supply Povidone K30 / K90 with:
- Full GMP-aligned manufacturing and stable lot-to-lot uniformity
- DMF/CEP documentation support for your registration timeline
- Multi-compendial compliance (USP/Ph.Eur./JP)
- Flexible pack sizes from R&D quantities to commercial bulk
We don't just move material — we make sure your QA team can actually file it.
Ask us for:
- Current COA and specifications
- DMF status and regulatory support package
- Sample for formulation evaluation
Key words:
News Hotspot